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ABSTRACT 
 
The maintenance of cellular levels of free fatty acids and acyl-CoAs, the activated form of 
free fatty acids, is extremely important as imbalances in lipid metabolism have serious 
consequences for human health. Acyl-CoA thioesterases (ACOTs) hydrolyze acyl-CoAs to 
the free fatty acid and CoASH, and thereby have the potential to regulate intracellular levels 
of these compounds. We have previously identified and characterized a mouse ACOT gene 
cluster, comprised of six genes that apparently arose by gene duplications, encoding acyl-
CoA thioesterases with localizations in cytosol (ACOT1), mitochondria (ACOT2) and 
peroxisomes (ACOT3-6). However, the corresponding human gene cluster contains only 
three genes, ACOT1, ACOT2 and ACOT4 coding for full-length thioesterase proteins, of 
which only one is peroxisomal (ACOT4). We therefore set out to characterize the human 
genes, and we here show that the human ACOT4 protein catalyzes the activities of three 
mouse peroxisomal ACOTs (ACOT3, 4, and 5), being active on succinyl-CoA and medium- 
to long-chain acyl-CoAs, while ACOT1 and ACOT2 carry out similar functions to the 
corresponding mouse genes. These data strongly suggest that the human ACOT4 gene has 
acquired the functions of three mouse genes by a functional convergent evolution that also 
provides an explanation for the unexpectedly low number of human genes.  
 
 
Keywords: β-oxidation, acyl-CoA, peroxisome, fatty acids. 
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INTRODUCTION 
Imbalances in fatty acid metabolism have serious consequences for human health and the 
onset and progression of several chronic diseases, such as coronary artery disease and 
atherosclerosis, dyslipidemia, obesity and diabetes. The central role of free fatty acids and 
acyl-CoAs (the activated form of fatty acids) is evident by the numerous intracellular 
processes in which these molecules are key components. These processes (reviewed in (1)) 
include oxidation of fatty acids (αβ and ω-oxidation), biosynthesis of lipids, and allosteric 
regulation of a number of enzymes (2-4) and opening of KATP-channels in human pancreatic 
beta-cells (5). There are, however, many processes that are activated by acyl-CoAs and 
inhibited by the free fatty acids or vice versa, showing the importance of maintaining the 
balance of these compounds in-vivo. It has recently been shown that palmitoyl-CoA inhibits 
AMP-activated protein kinase (AMPK) indirectly, by a specific and concentration dependent 
inactivation of its-upstream kinase (6). Another example where the balance of free fatty acids 
versus acyl-CoAs is important, is in the activation of the peroxisome proliferator-activated 
receptors (PPARs) by free fatty acids (7-10) and more recently also by CoA esters of long-
chain fatty acids (acyl-CoAs) (11). A recently recognized way in which the cell can control 
the intracellular acyl-CoA and free fatty acid levels is via the activity of enzymes named 
acyl-CoA thioesterases (ACOTs), which can hydrolyze acyl-CoAs to the corresponding free 
fatty acid and coenzyme A (CoASH) (for reviews see (12, 13)). These acyl-CoA thioesterases 
are expressed in several cellular compartments that coincide with metabolic processes 
involving acyl-CoAs. 
 
In 1995, a particular family of acyl-CoA thioesterases was identified in rat and was named 
Type-I acyl-CoA thioesterases (14). In the past few years, the cloning of cDNAs and genes 
have identified the Type-I acyl-CoA thioesterases to be a novel gene family with six 
members in mouse, a cytosolic isoform (Acot1, previously CTE-I), a mitochondrial isoform 
(Acot2, previously MTE-I), and four peroxisomal isoforms (Acot 3, 4, 5 and 6, previously 
PTE-Ia, -Ib, -Ic, and –Id) (15-17). Both the sequence similarity and the gene organization 
show a very high degree of conservation, suggesting that these genes have evolved by gene 
duplications. The identification of four peroxisomal ACOTs was surprising, but the 
characterization of their acyl-CoA substrate specificities showed that they catalyze distinct 
activities, and also show individual tissue expression. However, based on the multiple and 
important functions that peroxisomes play in degradation of a variety of lipids, which is 
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reflected in the severity of peroxisomal disorders (for reviews, (18, 19)), it is tempting to 
speculate that these ACOTs participate in regulation of β-oxidation and release of β-
oxidation products. In mouse, this Type-I gene cluster is located on mouse chromosome 12 
D3 within 120 kb of DNA. We have now characterized the genes in the corresponding gene 
cluster of Type-I ACOTs in human, which is localized on human chromosome 14q24.3. 
However, this cluster contains four genes of which three genes are transcribed to encode full-
length ACOTs and only one gene encodes a peroxisomal acyl-CoA thioesterase (ACOT4). 
We here show that the human ACOT4 gene apparently has evolved into a multifunctional 
protein that catalyzes the combined activities of mouse ACOT3, 4 and 5, while human 
ACOT1 and ACOT2 have similar functions to the mouse orthologs. 
 
MATERIALS AND METHODS 
 
Cloning and expression of acyl-CoA thioesterases  
Oligonucleotides were designed based on the sequence of the ORFs for human ACOT1, 
ACOT2, and ACOT4. Due to the very high sequence identity between ACOT1 and ACOT2 
it was not possible to PCR amplify individual transcripts of ACOT1 and ACOT2. We 
obtained the ACOT2 ORF using PCR amplification from human liver and purchased a clone 
containing the cDNA for ACOT1, Accession No. BM543491, (Image clone No. 5726581, 
UK HMGP Resource centre, Hinxton, UK) and used this as a template for PCR amplification 
of ACOT1. ACOT1 and ACOT2 were cloned into pET16b (Novagen Inc., Darmstadt, 
Germany) using the following primers: 5’-CATATGTCACTTTTGATGGGATTGTC-3’ and 
5’-CATATGGCGGCGACGCTGAT-3’ with NdeI sites indicated in bold. The ACOT4 was 
cloned into the pET102 (Invitrogen Corp., California, USA), in frame with thioredoxin. The 
5’ primer sequence was 5’-CACCATGTCAGCAACGCTGATCCTG-3’ and was constructed 
to contain an overhang of CACC for cloning into pET102. The 3’ primer sequence was 5’-
CAATTTAGGGACAGCTGTTTTCTG-3’. The ORF for ACOT4 was amplified by RT-PCR 
from human liver total RNA. RT-PCR was performed in a Perkin-Elmer 2600 using the One 
Step RT-PCR kit (Takara Biomedicals, Shiga, Japan). Thermal cycling was performed at 
50oC for 30 min and 94oC for 2 min, followed by 35 cycles of 94oC for 30 sec, 51.5oC for 30 
sec (ACOT2) or 60oC for 30 sec (ACOT4) and 72oC for 3 min. The resultant PCR products 
were cloned into pET102 or pET16b respectively and sequenced (Cybergene AB, Huddinge, 
Sweden).  
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The plasmids containing the human ACOT1, 2 and 4 were then used to transform 
BL21(DES3)pLysS cells (Novagen Inc., Darmstadt, Germany). Bacteria were cultured in 500 
ml Luria-Bertani medium at 37oC with addition of ampicillin (50 µg/ml) and 
chloramphenicol (34 µg/ml) until the OD600nm was approximately 0.6. Protein expression was 
induced by addition of 1 mM isopropyl-1-thio-β-D-galactopyranoside and cells were grown 
for 3 hours at 37oC (ACOT1 and ACOT2) or at 30 oC for 5 h (ACOT4). The recombinant 
proteins were purified as described previously and eluted using 500 mM imidazole (20). The 
purity of the expressed proteins was examined using SDS/PAGE analysis and Coomassie 
Brilliant blue staining and these purified proteins were used to measure acyl-CoA 
thioesterase activity. Mouse ACOT3, 4 and 5 recombinant proteins were produced as 
outlined in (16, 17) and activity measured with various acyl-CoA substrates. 
 
Northern blot analysis  
Human Multiple Tissue blots were purchased from Clontech Inc (Palo Alto, California, 
USA), and analysis was carried out according to the Manufacturers instructions, using α-32P-
labeled cDNA probes. The cDNA probes for the human ACOTs were constructed using RT-
PCR from human liver total RNA. For ACOT1 and ACOT2, a cDNA probe was amplified 
corresponding to amino acids 167-371 of the open reading frame (ORF) (shown in Fig. 2). 
The ACOT4 cDNA probe was amplified corresponding to amino acids 215 to 405 of the 
ORF and a specific probe located in the mitochondrial targeting signal of ACOT2 was 
amplified corresponding to amino acids 21 to 59 of the ORF.  
 
Enzyme activity measurements  
ACOT activity was measured spectrophotometrically at 412 nm with 5,5’-dithiobis(2-
nitrobenzoic acid) (DTNB). The medium contained 200 mM potassium chloride, 10 mM 
HEPES and 0.05 mM DTNB (pH 7.4). An E412=13,600 M-1cm-1 was used to calculate the 
activity. The acyl-CoA substrates used were obtained from Sigma-Aldrich Inc. (St. Louis, 
USA). The addition of bovine serum albumin (BSA) to prevent substrate inhibition with CoA 
esters was titrated for long-chain acyl-CoAs (C16-C20-CoA). A BSA:C18-CoA molar ratio 
of 1.8:1 was used in measuring ACOT1 and ACOT2 activities. Otherwise addition of BSA 
was not required for measurement of acyl-CoA thioesterase activity. 
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Cellular localization of human ACOTs using green fluorescent fusion protein  
The ORFs for the human ACOT1, 2, 4 and 6 were cloned as fusion proteins with green 
fluorescent protein (GFP) to examine the intracellular localization of the proteins. ACOT6 
was amplified using primers 5’-ATGCTGCAGCATCCAAAGGTG-3’ and 5’-
TCTGTCAAGCACAGCAAAATATAA-3’. The ORFs were amplified using PCR and the 
PCR products for ACOT1, ACOT4 and ACOT6 were cloned into the pcDNA3.1/NT-GFP 
vector (Invitrogen Corp., California, USA), in-frame with the GFP, leaving the 
carboxyterminal end accessible. The ACOT2 was cloned in-frame with the pcDNA3.1/CT-
GFP (Invitrogen Corp., California, USA), leaving the N-terminal end accessible. Sequence 
analysis was performed using Big Dye Terminator Ready Reaction kit (Perkin Elmer Inc., 
Wellesley, MA, USA) and was sequenced by Cybergene AB (Huddinge, Sweden).  
 
Human skin fibroblasts or HepG2 cells were grown in Eagles MEM (Sigma-Aldrich Inc., St. 
Louis, USA), supplemented with 10% fetal calf serum (Invitrogen Corp., California, USA) 
and 100 U penicillin/100 µg streptomycin in an atmosphere of 5% CO2. Cells were grown 
overnight in 60 mm dishes on glass coverslips and were transfected with 10 µg of the various 
plasmids using Calcium Phosphate method as described previously (20). The localization of 
ACOT1, ACOT4 and ACOT6 was investigated in fibroblasts, and in the case of ACOT4, 
skin fibroblasts from a Zellweger patient were also used. The localization of ACOT2 was 
investigated in HepG2 cells and Mitotracker® Orange CMTMRos (Invitrogen Corp., 
California, USA) was used to confirm mitochondrial structures. Transfected cells were grown 
for 48 hours and fibroblasts were treated for immunofluorescence as described (20). HepG2 
cells treated with 200 nM Mitotracker® Orange for 30 mins before immunofluorescence 
microscopy was carried out as previously described (20), but without use of the Tritc-labeled 
antibody. 
 
RESULTS 
Identification of a human ACOT gene cluster  
Previous data had identified six mouse Acot genes in a cluster which are located within 120 
kb on mouse chromosome 12 D3 (15-17). Database searches using the cDNA sequences for 
the mouse Type-I Acot genes identified four putative human ACOT genes on chromosome 
14q24.3, located within 80 kb of genomic sequence (Fig. 1). Based on homology to the 
mouse genes, we identified the putative human orthologs of Acot1, Acot2, Acot4 and Acot6 in 
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the human gene cluster. The distance between the genes is approximately 25.7 kb between 
ACOT1 and ACOT2, 16.5 kb between ACOT2 and ACOT4 and 16.9 kb between ACOT4 and 
ACOT6. Comparison of the two gene clusters reveals two striking differences, firstly that the 
order of the ACOT1 and ACOT2 genes are different in the human genome compared to 
mouse, and second, that the human gene cluster only contains one putative gene encoding a 
peroxisomal ACOT. Similar to the mouse genes, the open reading frames for three of these 
genes are coded for by three exons (ACOT1, ACOT2 and ACOT4) whereas the fourth gene 
identified in the cluster, ACOT6, contained the genomic information for all 3 exons (which 
would result in a full-length ACOT protein), but apparently is translated from a methionine at 
the end of exon 2 through exon 3. This is based on EST sequences, the estimated size of the 
transcript detected by Northern blot (data not shown), and the facts that we could not amplify 
the predicted full-length open reading frame, but we could amplify a transcript that covered 
part of exon 2 and exon 3.  
 
Data base searches in the entire human genome did not indicate the presence of any other 
genes that would correspond to mouse Acot3 or Acot5, but a further gene was identified on 
chromosome 19q13.12 that shows 91% sequence identity at nucleotide level to the ACOT4 
gene on chromosome 14. However, this gene on chromosome 19 lacks introns and contains 
several stop codons, which will not result in active protein. Interestingly, searches in EST 
databases show that the pseudogene is expressed in purified pancreatic islets (EST No. 
CA843741, CB177282 and CA843493), brain (EST No. BI827748 and AW090080), and 
placenta (EST No. DB328688 and DA849162).
 
 
Alignment of the deduced amino acid sequences for the open reading frames of the ACOT1, 
ACOT2 and ACOT4 genes shows the striking conservation between the various ACOTs (Fig. 
2). The ACOT1 and ACOT4 genes encode proteins of 421 amino acids, with the latter 
containing -PKL at its carboxyterminal, which is a variant of the peroxisomal type-1 
targeting signal (PTS1) that can target proteins to peroxisomes (21). ACOT2 encodes a 
protein of 483 amino acids and contains a 62 amino acid leader sequence at the N-terminal, 
which targets the protein to mitochondria (see below). The 421 amino acids of ACOT2 that 
align to ACOT1 show 98.6% sequence identity, with only 5 amino acids being different. The 
three amino acids identified to be the catalytic triad of the active site in the mouse ACOT 
enzymes (22), a serine (acting as the nucleophile) in a Gly-X-Ser-X-Gly motif common to 
serine esterases, a histidine and an aspartic acid are all conserved in the human enzymes 
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(indicated in Fig. 2). The serine is located at position 232 of ACOT1, the aspartic acid at 326 
and the histidine at 360.  
 
Subcellular localization of the human ACOTs 
The subcellular localization of the four human ACOTs identified in this study was examined 
by expression of the ACOTs in human skin fibroblasts and HepG2 cells as GFP fusion 
proteins. The rationale for choosing either N-terminal or C-terminal GFP was based on the 
presence of putative targeting signals at the N- or C-terminal ends, and also on previous data 
obtained for localization of the mouse orthologs. The ACOT1 (homologous to the mouse 
ACOT1 which is cytosolic (23)) contains no apparent targeting signal but contains a PTS1-
like sequence of –SKV at its C-terminal end. However transfection of this GFP fusion protein 
into human fibroblasts resulted in a protein with a diffuse pattern of expression with no 
visible punctate staining, in line with a cytosolic localization (Fig. 3A). ACOT6 also contains 
a PTS1-like sequence of –SKI at its C-terminal end but this GFP fusion protein was also 
localized in cytosol (Fig. 3B). The ACOT2 protein contains a putative mitochondrial-
targeting signal at its N-terminal end. This GFP fusion protein showed a typical pattern for 
mitochondrial localization as judged by immunofluorescence microscopy (Fig. 3C). Use of a 
mitotracker confirmed that the ACOT2 fusion protein was localized in mitochondria (Fig. 
3D). The human ACOT4 contains a near-consensus PTS1 of -PKL at its C-terminal, which is 
also present in C. tropicalis sterol carrier protein (POX18), and has been shown to target 
proteins to peroxisomes (24). We transfected the ACOT4/NT-GFP vector into both control 
fibroblasts and fibroblasts from a Zellweger patient, which are unable to import peroxisomal 
matrix proteins. Using immunofluorescence microscopy for GFP detection, ACOT4 showed 
a punctate pattern of expression in control fibroblasts, indicative of a peroxisomal 
localization (Fig. 3E). However, in Zellweger fibroblasts, transfection of ACOT4 resulted in 
a diffuse GFP expression, showing an inability of the protein to be imported into peroxisomes 
(Fig. 3F).  
 
Recombinant expression and characterization of human and mouse ACOT proteins 
The cloning of the open reading frames of ACOT1 and ACOT2 into pET16b and ACOT4 into 
pET102 vectors resulted in expression of these proteins as His-tagged fusion proteins, to 
allow for purification using affinity chromatography. Following purification on a HiTrap™ 
column, the purified ACOT1 and ACOT2 were detected as single bands of approximately 46 
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kDa in mass on SDS/PAGE gel stained with Coomassie Brilliant blue, whereas ACOT4 was 
detected as an approximately 60 kDa band as a thioredoxin fusion protein (data not shown).  
 
The human ACOT4 gene shows strongest similarity to ACOT4 in mouse, and is therefore 
likely to be the human ortholog of mouse ACOT4. The mouse ACOT4 enzyme was recently 
shown to be a highly specific succinyl-CoA thioesterase, with only low activity with glutaryl-
CoA and no activity with any other tested acyl-CoAs (17). In line with this, characterization 
of recombinant human ACOT4 indeed showed highest activity with succinyl-CoA (Vmax≈581 
nmol/min/mg protein, and Km≈14 µM), with much lower Vmax and higher Km with glutaryl-
CoA (132 nmol/min/mg protein and 147 µM, respectively). Surprisingly, ACOT4 was also 
active on all long-chain saturated acyl-CoAs of >8 carbon atoms as well as all tested 
unsaturated acyl-CoAs (C18:1, C18:2 and C20:4). The calculated Vmax and Km values of 
ACOT4 with C14-CoA (which was the best long-chain acyl-CoA substrate) were 137 
nmol/min/mg protein and 3.4 µM, respectively. Fig. 4A summarizes the activity of human 
ACOT4 with all acyl-CoAs tested, demonstrating that human ACOT4 is a succinyl-CoA 
thioesterase that also hydrolyzes long-chain saturated and unsaturated monocarboxylic acyl-
CoAs. The pattern of activity of human ACOT4 mirrors the combined activities of the 
recently characterized mouse ACOT3, ACOT4 and ACOT5 proteins (summarized in Fig. 
4B). Therefore the human peroxisomal ACOT4 can replace the function of 3 distinct 
peroxisomal enzymes in mouse. Interestingly, although succinyl-CoA (C4-dicarboxylyl-
CoA) was the best substrate for ACOT4, the corresponding C4-monocarboxylyl-CoA 
(butyryl-CoA) was not a substrate, and in contrast the C12 dicarboxylyl-CoA was not a 
substrate in spite of the fact that the corresponding C12 monocarboxylyl-CoA was a good 
substrate (data not shown). These data demonstrate that human ACOT4 has not simply 
evolved into a non-specific acyl-CoA thioesterase, but rather that human ACOT4 has 
acquired the combined activities of mouse ACOT3, ACOT4 and ACOT5. 
 
Kinetic characterization of recombinant human ACOT1 and ACOT2 showed very similar 
substrate specificities, with both enzymes being mainly active on long-chain saturated acyl-
CoAs of 12 to 20 carbon atoms, and long-chain unsaturated acyl-CoAs such as C16:1-CoA, 
C18:1-CoA (Fig. 5A and B). The data thus show that ACOT1 and ACOT2 function as long-
chain acyl-CoA thioesterases with no detectable activity with acyl-CoAs of 8 carbon atoms or 
shorter. Kinetic characterization of ACOT1 and ACOT2 show that the Km for long-chain 
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acyl-CoAs is in the low µM range, demonstrating that these are probably the in-vivo 
substrates for the enzymes (Table I).  
 
Tissue expression of human ACOTs 
Northern blot analysis was carried out to examine the tissue expression of the various human 
ACOTs (Fig. 6). As ACOT1 and ACOT2 in human show 99% sequence identity to eachother, 
it was not possible to make a probe that would be specific for the ACOT1. Using a cDNA 
probe to ACOT1/ACOT2, one transcript of approximately 1.8 kb was detected with highest 
levels in heart, liver, muscle and kidney. However, a cDNA probe corresponding to the 
mitochondrial-targeting signal of the ACOT2 was constructed, which will distinguish 
between these two mRNAs. Using the ACOT2 specific probe, the mRNA signal was again 
strongest in heart, liver, muscle and kidney and also weakly in placenta and pancreas, 
suggesting that ACOT2 is much more strongly expressed than ACOT1. This is further 
supported by searches in the EST database, which showed that ESTs corresponding to 
ACOT2 were much more abundant than ESTs corresponding to ACOT1. The ACOT4 was 
detected as two transcripts of approximately 1.7 and 2.2 kb, with strongest expression in liver 
and kidney and weaker expression in placenta, heart and muscle. These two transcripts were 
differentially expressed with the lower transcript expressed mainly in liver and kidney, 
whereas the upper transcript was detectable in heart, liver, muscle and kidney.  
 
DISCUSSION 
 
We have previously identified and characterized a gene cluster on chromosome 12 D3 in 
mouse (15-17), containing six individual genes, Acot1 (cytosolic), Acot2 (mitochondrial) and 
Acot3, 4, 5 and 6 (all peroxisomal). Here we have characterized the corresponding cluster in 
human, which consists of four ACOT genes on chromosome 14q24.3. Three of these genes, 
ACOT1, ACOT2 and ACOT4 encode full-length ACOT proteins, and one gene, ACOT6, is 
translated from a methionine at the end of exon 2 into a putative open reading frame of only 
207 amino acids. Although the catalytic amino acids would be contained in the protein, it is 
not clear whether the protein will be active. Interestingly the mouse ACOT6 ortholog 
contains a canonical PTS-1 targeting signal of –SKL in the C-terminal end, which targets 
mouse ACOT6 to peroxisomes (Westin et al, unpublished results), while human ACOT6 
ends with an isoleucine instead of leucine (C-terminal end of -SKI), which results in a 
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cytosolic localization. It is remarkable that mouse contains so many peroxisomal ACOT 
enzymes, whereas human contains only one functional peroxisomal Type-I ACOT. However, 
our finding that human ACOT4 hydrolyzes succinyl-CoA, glutaryl-CoA and long-chain acyl-
CoAs, provides a plausible explanation for the difference in the number of peroxisomal 
ACOTs in human and mouse. In mouse, there are three Type-I ACOT enzymes characterized 
to date that hydrolyze straight-chain acyl-CoA esters, the ACOT3 active on long-chain acyl-
CoAs and the ACOT5 active on medium chain acyl-CoAs (16), together with ACOT4, a 
newly identified succinyl-CoA/glutaryl-CoA thioesterase (17). While mouse ACOT4 only 
hydrolyzes succinyl-CoA with high activity, and glutaryl-CoA with low activity, human 
ACOT4 also hydrolyzes saturated and unsaturated medium- to long-chain acyl-CoAs. It is 
therefore reasonable to suggest that human ACOT4 catalyzes the combined activities of 
mouse ACOT3, 4 and 5. Also, human ACOT4 is mainly expressed in liver and kidney, 
similar to mouse Acot3 and 4, further strengthening a functional redundancy. It would 
therefore be very interesting to compare this gene cluster in various species to trace the 
appearance/disappearence of genes in this cluster, and to follow the acquisition of the 
different activities in ACOT4 in higher vertebrates. A similar convergent evolution from 
mouse to human is seen among acyl-CoA oxidases, peroxisomal enzymes catalyzing the first 
reaction in the β-oxidation of various acyl-CoAs in peroxisomes. While rat and mouse have 
three genes encoding straight-chain acyl-CoA oxidase, trihydroxycoprostanoyl-CoA oxidase 
and branched-chain (pristanoyl-CoA) acyl-CoA oxidase, (25), human has only two genes 
encoding the straight-chain oxidase and a combined trihydroxycoprostanoyl-CoA and 
pristanoyl-CoA oxidase (26, 27). Interestingly, in human there is also an intron-less ACOT 
pseudogene located on chromosome 19q13.12, which shows very high similarity to ACOT4. 
Although this pseudogene is expressed at mRNA level in several tissues, the function is not 
known. However, recently it was shown that a pseudogene of the Makorin 1 gene (Makorin 
1-p1) could regulate the mRNA stability of its homologous coding gene (28). Therefore the 
ACOT pseudogene may have a regulatory function on the expression of ACOT4. The fourth 
gene in the ACOT gene cluster, ACOT6, contains the genetic information for all three coding 
exons common to the ACOT genes described in this work, however, translation apparently 
starts from a methionine present at the end of exon 2. We were able to amplify a PCR product 
containing this truncated open reading frame of ACOT6, but it is not known whether ACOT6 
is expressed as an active protein. The corresponding mouse ACOT6 gene encodes a 46 kDa 
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protein that is expressed, but as yet the substrate for this enzyme has not been defined 
(Westin et al, unpublished results).  
 
Cloning and sequence analysis of ACOT1 and ACOT2 revealed open reading frames 
encoding proteins of 421 amino acids that aligned to eachother, with 98.6% sequence 
identity. While ACOT2 contains a further 62 amino acids in-frame at the N-terminal end that 
functions as a mitochondrial targeting signal, ACOT1 lacks these amino acids. ACOT2 was 
previously cloned as a human peroxisomal acyl-CoA thioesterase named PTE2 (29), however 
sequence alignment of PTE2 reveals that it relates to ACOT2 without its mitochondrial 
targeting signal. The assignment of the name PTE2 was based on the finding that the -SKV 
tripeptide at the C-terminal end acted as a weak peroxisomal targeting signal, mediating some 
import of this protein into peroxisomes. Indeed it has been shown that mutation of the 
peroxisomal targeting signal from the consensus –SKL to -SKV results in mistargeting to 
cytosol (30). We now show that ACOT2 contains a mitochondrial-targeting signal at its N-
terminal end, which targets the protein to mitochondria. In line with the apparent lack of 
targeting signals in ACOT1, the protein remained in the cytosol in the GFP experiments.  
 
Mouse and human peroxisomes contain a further acyl-CoA thioesterase now renamed 
ACOT8 (previously called PTE1, hTE, hACTEIII and PTE-2) in a new acyl-CoA 
thioesterase nomenclature system (31), which can hydrolyze a wide variety of CoA esters, 
including bile acid-CoAs, branched-chain-CoAs and long- medium- and short chain acyl-
CoAs (20, 32). Therefore it appears that mouse peroxisomes contain 5 different peroxisomal 
acyl-CoA thioesterases, hydrolyzing a broad spectrum of CoA esters, whereas human 
contains only 2 genes coding for peroxisomal acyl-CoA thioesterases, whose activity cover 
the same span of CoA ester substrates. The need for several peroxisomal ACOT enzymes 
with different specificities becomes evident in view of the multiple functions that 
peroxisomes play in chain-shortening of various carboxylic acids (as peroxisomes do not 
catalyze complete β-oxidation of lipids), including long- and very long-chain fatty acids, 
dicarboxylic acids, bile acid intermediates and xenobiotic carboxylic acids (19, 33). 
Furthermore, fatty acids are apparently transported across the peroxisomal membrane as 
CoA-esters (in contrast to mitochondria that utilizes a carnitine-acylcarnitine transport 
system), while fatty acid degradation products may be transported out of the peroxisome as 
carnitine esters, glycine or taurine conjugates or as the free acids. This implies that ACOTs 
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may serve essential functions in peroxisomes to regulate β-oxidation (CoASH levels) as well 
as in termination of β-oxidation at various chain-lengths for exit out of the organelle. In view 
of this, we were surprised to only find one peroxisomal Type-I ACOT in the human genome. 
However, the finding here that ACOT4 in fact catalyzes the activities of three mouse ACOTs 
not only explains the lower number of human ACOT genes, but also underscores the 
physiological importance of these ACOTs in peroxisomal lipid metabolism. 
 
ACOTs play key roles in maintaining the intracellular ratio between the CoA esters of 
various lipids and the free acid e.g. acyl-CoAs and free fatty acids. Putative functions for 
these ACOT enzymes in cytosol, mitochondria and peroxisomes have been described in 
detail in a recent review, mainly based on work carried out on the mouse enzymes (12). 
ACOT1 and ACOT2 have very similar substrate specificities, both active on long-chain acyl-
CoAs, which is not surprising based on their extremely high level of sequence identity 
(>98%). However, these enzymes show two distinct cellular localizations in cytosol and 
mitochondria and therefore have specific functions within these compartments in the 
metabolism of long-chain acyl-CoAs. In mitochondria, ACOT2 has been suggested to be 
involved in a co-ordinate shuttle pathway together with uncoupling protein 3 (UCP3) in 
muscle and brown adipose tissue (34).  This hypothesis suggests that free fatty acids are 
shuttled out of the mitochondria by UCP3 when fatty acid β-oxidation predominates. These 
free fatty acids would result from the hydrolysis of acyl-CoAs by ACOT2, thus releasing 
CoASH for further reactions within the mitochondria during β-oxidation. The free fatty acids 
transported out of the mitochondria by UCP3 would then be reactivated by acyl-CoA 
synthetases to form acyl-CoAs, which could subsequently be transported back into the 
mitochondria as a carnitine ester via the sequential action of carnitine palmitoyl transferase I 
(CPTI) and the carnitine acylcarnitine (CAC) transporter. This shuttle mechanism would 
prevent overloading of the mitochondria with acyl-CoA and trapping of CoASH, which is 
vital for β-oxidation and the citric acid cycle to proceed. A role for ACOT1 has been 
suggested in control of ligand supply for the PPAR family of nuclear receptors in the form of 
acyl-CoAs or free fatty acids and/or channeling fatty acids toward degradation rather than 
esterification (22).  
 
In summary, the identification of a family of human acyl-CoA thioesterases with distinct 
tissue expression and substrate specificities opens up avenues for further research into these 
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enzymes, which may be important in regulation of numerous intracellular processes, as well 
as for maintaining robustness in response to rapid changes in availability of energy 
substrates. Patients with lowered ACOT activity have recently been described (35), however, 
no patients deficient in the Type-I family of ACOT enzymes characterized in this study have 
yet been identified. The role of ACOT enzymes in lipid metabolism within different 
intracellular compartments suggests that future studies may reveal their importance in inborn 
errors of metabolism and lipid metabolism.  
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FIGURE LEGENDS 
 
Fig. 1. Organization of the human and mouse ACOT gene clusters. Analysis of human 
genomic DNA sequences was carried out as described in ‘Materials and Methods’. The 
localization of the four ACOT genes is shown on chromosome 14q24.3. The open reading 
frames for ACOT1, ACOT2 and ACOT4 are encoded for by three exons, whereas ACOT6 is 
encoded from a methionine at the end of exon 2. The ACOT gene cluster in mouse consists 
of six genes, Acot1-6. Note the different order of the Acot1 and Acot2 genes in mouse 
compared to human, and that the cellular localization for each gene product is indicated. The 
open square on mouse and human ACOT2 indicate the presence of N-terminal mitochondrial 
targeting signals. 
 
Fig. 2. Sequence alignment of human ACOTs. Alignment of human ACOT1, ACOT2 and 
ACOT4 was performed using Clustal X. The individual exon boundaries for the ACOTs are 
indicated. ACOT2 contains a 62 amino acid mitochondrial targeting signal at its N-terminal 
end. The active site serine, conserved in a Gly-X-Ser-X-Gly motif, the histidine, and the 
aspartic acid residues of the catalytic triad are all indicated with black arrowheads. 
 
Fig. 3. Intracellular localization of human ACOTs. Human skin fibroblasts were 
transfected with plasmids that expressed GFP fusion proteins of ACOT1, ACOT4 and 
ACOT6 and HepG2 cells were tranfected with a GFP fusion protein plasmid of ACOT2. 
Cells were fixed and processed for immunofluorescence microscopy. The distribution of 
ACOT1 and ACOT6 was examined in control fibroblasts using a Tritc-labelled anti-GFP 
antibody. ACOT2 localization was examined in HepG2 cells and Mitotracker® Orange 
CMTMRos was used to confirm mitochondrial structures. (A) ACOT1, (B) ACOT6 (C) 
ACOT2, (D) Mitotracker CMTMRos. The distribution of ACOT4 was investigated in 
fibroblasts from a control subject (E) and in fibroblasts from a Zellweger patient (F).  
  
Fig. 4. Human ACOT4 catalyzes the combined activities of mouse ACOT3, ACOT4 and 
ACOT5. (A) Expression of recombinant human ACOT4 in pET102 was induced as 
described in ‘Materials and Methods’. The substrate specificity for purified human ACOT4 
was examined with various CoA esters and measured at 25 µM. (B) The figure shows the 
specific activities of mouse ACOT3, ACOT4 and ACOT5 on various acyl-CoAs measured at 
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25 µM substrate concentration. Note that the activities of the monocarboxylic acyl-CoAs of 
ACOT3 and ACOT5 are shown in stack columns. Dicarboxylic acids; C4, succinyl-CoA; C5, 
glutaryl-CoA.  
 
Fig. 5. Acyl-CoA substrate specificities of human ACOT1 and ACOT2. Human ACOT1 
and ACOT2 were expressed in BL21(DES3)pLysS cells and purified as described in 
‘Materials and Methods’. The purified recombinant proteins were used to measure 
thioesterase activity with various acyl-CoAs at 15 µM. (A) ACOT1 (B) ACOT2.  
BSA:acyl-CoA in a molar ratio of 1.8:1 was used in measuring C18-CoA thioesterase 
activity. 
 
Fig. 6. Tissue expression of human ACOTs.  Northern blot analysis was carried out on a 
Human Multiple Tissue Blots using α-32P-labeled cDNA probes for ACOT1, ACOT2 and 
ACOT4 as described in ‘Materials and Methods’. 
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Table I.  Recombinant  human ACOT1 and ACOT2 were purified and characterized for acyl-
CoA thioesterase activity with various acyl-CoAs. Km and Vmax values were calculated using 
the Sigma Plot or GraphPad Prism 4 enzyme kinetics programs. Km and Vmax values were 
determined for saturated acyl-CoAs on two different protein preparations, and data are shown 
as mean±range of two experiments. Activity was measured on unsaturated acyl-CoAs using 
one protein preparation. 
 
 
 
 
               ACOT 1               ACOT2 
Acyl-CoA Km  
(µM) 
Vmax 
(nmol/min/mg) 
Km 
(µM) 
Vmax 
(nmol/min/mg) 
C10 35.8±5.2 224±50 40.3±0.7 212±26 
C12 3.6±1.0 700±152 8.9±0.2 681±94 
C14 2.8±0.2 912±199 1.6±0.0 766±155 
C16 3.6±2.6 691±42 2.0±0.6 656±3 
C18 2.4±0.6 597±145 2.8±1.6 488±122 
C20 2.0±0.2 520±41 4.8±2.0 408±64 
     
C16:1 2.4 577 4.5 661 
C18:1 4.1 258 6.1 304 
C18:1 trans 2.1 309 4.3 418 
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